The U.S. government program that provides free at-home COVID tests is no longer accepting orders.
Remibrutinib beneficial for urticaria after H1-antihistamine treatment
For patients with symptomatic chronic spontaneous urticaria after treatment with second-generation H1-antihistamines, administration of the oral, highly selective Bruton’s tyrosine kinase inhibitor, remibrutinib, results in a significant improvement in a composite measure of itching and hives at week 12, according to a study published in the March 6 issue of the New England Journal of Medicine.
More research needed on preventive service use by people with disabilities
Evidence relating to barriers to and facilitators of clinical preventive service use in people with disabilities is limited, according to a review published online March 11 in the Annals of Internal Medicine.
Blood metabolites may reduce genetic risk of glaucoma
Scientists have revealed why not all individuals with a high inherited risk of glaucoma may ultimately develop the disease.
Measles cases are still rising in Texas. Here’s what you should know about the contagious virus
Measles outbreaks in West Texas and New Mexico are now up to more than 250 cases, and two unvaccinated people have died from measles-related causes.
AI-driven robotics research aims to enhance care for older adults with Alzheimer’s
Imagine a robot that not only reminds you to take your medication, but helps you navigate your home and offers companionship. This type of artificial intelligence (AI)-powered technology could be a reality for seniors in the not-too-distant future.
From TB to HIV/AIDS to cancer, disease tracking has always had a political dimension
Federal datasets began disappearing from public view on Jan. 31, 2025, in response to executive orders from President Donald Trump. Among those were the Centers for Disease Control and Prevention’s Youth Risk Behavior Survey, which asks respondents about their gender identity and sexual orientation and tracks behaviors like smoking and drug use; CDC’s HIV dataset; and CDC and Agency for Toxic Substances and Disease registry’s Environmental Justice Index, which tracks pollution in communities, and Social Vulnerability Index, which identifies communities at high risk for disease and disability.
Study quantifies loss of disability-free years of life from COVID-19 pandemic
Among 289 million adults in 18 European countries, more than 16 million years of life were lost from 2020 through 2022 due to the COVID-19 pandemic, according to a study published in the open-access journal PLOS Medicine by Sara Ahmadi-Abhari of Imperial College London, UK, and colleagues.
End-of-life planning can be hampered by misconceptions, but the process is easier than you might think
During the COVID-19 pandemic, many people unexpectedly needed critical care such as ventilators but were unable to communicate their end-of-life wishes to their loved ones.
Study shows how neurofilaments act like Velcro to clog up brain functions
Northwestern Medicine scientists have uncovered new insights into how neurofilaments act like Velcro in neurodegenerative diseases, clogging up the brain and preventing normal function, according to a study published in the journal JCI Insight.